
Will pharma finally score a policy win for 340B?
The 340B Drug Pricing Program has long been a contentious issue for pharma. Aimed at providing discounted drugs to hospitals in lower income areas, pharma leaders argue the program is vulnerable to abuse and sometimes boosts hospital profits without …